[1] | WHO, 2001, Mental and Neurological Disorders. Fact Sheet No. 25. |
[2] | Nutt, D.J., 2005, Overview of diagnosis and drug treatments of anxiety disorders., CNS Spectrums, 10, 49-5. |
[3] | Del Amo, S., 1979, Catàlogo de plantas medicinales del estado de Veracruz., Xalapa: INIRB, 9, 279. |
[4] | Wahida, B., Abderrahman, B., and Nabil C., 2007, Antiulcerogenic activity of Zizyphus lotus (L.) extracts., Journal of Ethnopharmacology, 112, 228-31. |
[5] | Ngo Bum, E., Soudi, S., Ayissi, E.R., Dong, C., Lakoulo, N. H., Maidawa, F., Seke, P.F.E., Nanga, L.D., Taiwe, G.S., Dimo, T., Njifutie Njikam, Rakotonirina, A. Rakotonirina, S. V. and Kamanyi, A. 2011, Anxiolytic activity evaluation of four medicinal plants from Cameroon., African Journal of Traditional Complementary and Alternative Medicine 8(S), 130-139. |
[6] | Mbomo, R. A., Gartside S., Ngo Bum E, Njifutie Njikam, Okello, E., and McQuade, R., 2012, Effect of Mimosa pudica (Linn.) extract on anxiety behaviour and GABAergic regulation of 5-HT neuronal activity in the mouse., Journal of Psychopharmacology. |
[7] | Borsini, F., Lecci, A., Volterra, G., and Meli, A., 1989, A model to measure anticipatory anxiety in mice., Psychopharmacology, 98, 207-211. |
[8] | Bourin, M., Hascoet, M., Mansouri, B., Colombel, M.C., and Bradwejn, J., 1992, Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models., Journal of Psychiatry and Neurosciences, 17, 72-7. |
[9] | Handley, S.L., and Mithiani, S., 1984, Effects of alpha 2 adrenoceptor agonists and antagonists in a maze explorating model of fear-motivated behave., Pharmacology, 327, 1-5. |
[10] | Hall, C.S., 1934, Emotional behavior in rat. Defecation and urination as measures of individual differences in emotionality., Journal of Comparative Psychology, 18, 382-403. |
[11] | Belzung, C., 1999. Measuring rodent exploratory behavior. In: Crusio W.E., and Gerlai Edition, Handbook of Molecular-Genetic techniques. Brain and Behavioural Research, 11, 738-749. |
[12] | Takeda, H., Tsuji, M., and Matsumiya, T., 1998, Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice., European Journal of Pharmacology, 350, 21-29. |
[13] | Roome, T., Dar, A., Naqvi, S., Choudhary, M.I., 2011, Evaluation of antinociceptive effect of Aegiceras corniculatum stems extracts and its possible mechanism of action in rodents., Journal of Ethnopharmacology, 135, 351-358. |
[14] | Pieretti, S., Piaz, V.D., Matucci, R., Giovannoni, M.P., and Galli, A., 1999, Antinociceptive activity of a3(2H)-pyridazinone derivative in mice., Life Science, 65, 1381-1394. |
[15] | Hui, K.M., Huen, M.S., Wang, H.Y., Zheng, H., Sigel, E., Baur, R., Ren, H., Li, Z.W., Wong, J.T., and Xue, H., 2002, Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi., Biochemistry and Pharmacology, 64, 1415-1424. |
[16] | Huen, M.S., Leung, J.W., Lui, W.S., Chan, M.N., Wong, J.T., and Xue, H., 2003, 5,7-Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties., Biochemistry and Pharmacology, 66, 125-132. |
[17] | Zethof, T.J., Van der Heyden, J.A., Tolboom, J.T., and Olivier, B., 1995, Stress-induced hyperthermia as a putative anxiety model., European Journal of Pharmacology, 294, 125-135. |
[18] | Olivier, B., Zethof, T., Pattij, T., van Boogaert, M., van Oorschot, R., Leahy C., Oosting, R., Bouwknecht, A., Jan, V., Jan van der G., and Groenink, L. 2003, Stress-induced hyperthermia and anxiety: pharmacological validation., European Journal of Pharmacology, 463:117-132. |
[19] | Lister, R.G., 1990, Ethologically based animal models of anxiety disorders, Pharmacology and Therapeutics., 46, 321-340. |
[20] | Rodgers, R.J., and Dalvi, A., 1997, Defense and the Elevated Plus Maze., Neurosciences and Biobehavioral Review, 21, 8016-810. |
[21] | Dawson, G.R., and Tricklebank, M.D., 1995, Use of the elevated plus maze in the search for novel anxiolytic agents., Trends in Pharmacological Sciences, 16, 33-36. |
[22] | Cruz, A.P., Frei, F., and Graeff F.G., 1994, Ethnopharmacological analysis of rat on the elevated plus maze., Pharmacology Biochemistry and Behavior, 49,171-176. |
[23] | Ngo Bum, E., Dawack, D.L., Schmutz, M., Rakotonirina, A., Rakotonirina, S.V., Portet, C., et al. 2004. Anticonvulsant activity of Mimosa pudia decoction. Fitoterapia 75(3-4), 309-314. |
[24] | Costa, E., and Guidotti, A., 1996, Benzodiazepine on trial: a research strategy for their rehabilitation., Trends in pharmacological Sciences, 17,192-200. |
[25] | Atack, J.R., 2003, Anxioselective compounds acting at the GABAA receptor benzodiazepine binding site. Current drug targets., CNS and Neurological Disorders, 2, 213-232. |
[26] | Leonard, B.E., 1992, Fundamentals of Psychopharmacology., Chichester: John Wiley and Sons. |
[27] | Walsh, R.N., and Cummins, R.A., 1976, The open-field test: a critical review., Psychology Bulletin, 83, 482-504. |
[28] | Prut, L., and Belzung, C., 2003, The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review., European Journal of Pharmacology, 463, 3-33. |
[29] | Rakotonirina, S.V., Ngo Bum, E., Rakotonirina, A., and Bopelet, M., 2001, Sedatives properties of decoction of the rhizomes of Cyperus articulates., Fitoterapia, 72, 22-29. |
[30] | Choleris, E., Thomas, A.W., Kavaliers, M., and Prato F.S., 2001, A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely frequency pulsed agnetic field., Neurosciences and Biobehavioral Review, 25, 235-260. |
[31] | Vinade, E.R., Schmidt, A.P., Frizzo, M.E., Izquierdo, I., Elisabetsky, E., and Souza, D.O., 2003, Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice., Brain Research, 977, 97-102. |
[32] | Dawson, G. R., Maubach, K. A., Collinson, N., Cobain, M., Everitt, B. J., MacLeod, A. M., Choudhury, H. I., McDonald, L. M., Pillai, G., Rycroft, W., Smith, A. J., Sternfeld, F., Tattersall, F. D., Wafford, K. A., Reynolds, D. S., Seabrook, G. R., and Atack J. R., 2006, An Inverse Agonist Selective for 5 Subunit-Containing GABAA Receptors Enhances Cognition., Journal of Pharmacology and Experimental Therapeutics, 316, 1335-1345. |
[33] | Medina, J.H., Paladini, A.C., Wolfman, C., Levi De Stein, M., Calvo, D., Diaz, L., and Pena, C., 1990, Chrysin (5-7 di OH flavone), a naturally-occurring ligand for benzodiazepine receptors with anticonvulsant properties., Biochemical Pharmacology, 40, 2227-2232. |
[34] | Blanchard, D.C., and Blanchard, R.J., 1988, Ethoexperimental approaches to the biology of emotion., Annual Review of Psychology, 39, 43-68. |
[35] | Rodgers, R.J., Cole, J.C., and Davies, A., 1994, Anti-anxiety and behavioral suppressant actions of the novel 5- HT1A receptor agonist, flesinoxan., Pharmacology Biochemistry Behavior, 48, 959-963. |
[36] | Griebel, G., Belzung, C., Perrault, G., and Sanger D.J., 2000, Differences in anxiety related behaviors and in sensitivity to diazepam in inbred and outbred strain of mice., Psychopharmacology, 148, 114-117. |
[37] | Dunhan, N.W., and Miya, T.S., 1957, A note on a simple apparatus for detecting neurological deficit in rat and mice., Journal of the American Pharmaceutical Association 46, 208-209. |